v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Class A common stock
Class A common stock
Common Stock
Beginning balance (in shares) at Dec. 31, 2023           25,978,863
Beginning balance at Dec. 31, 2023 $ 228,017 $ 1,527,778 $ (1,300,188) $ 425   $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (20,239)   (20,239)      
Common stock issued pursuant to stock option exercises (in shares)           4,877
Common stock issued pursuant to stock option exercises 24 24        
Stock-based compensation expense (451) (451)        
Other comprehensive income (loss), net of tax (134)     (134)    
Vested restricted stock units converted to common stock (in shares)           138,608
Ending balance (in shares) at Mar. 31, 2024           26,122,348
Ending balance at Mar. 31, 2024 $ 207,217 1,527,351 (1,320,427) 291   $ 2
Beginning balance (in shares) at Dec. 31, 2024 28,016,545         28,016,545
Beginning balance at Dec. 31, 2024 $ 245,247 1,596,889 (1,352,474) 830   $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (6,529)   (6,529)      
Common stock issued pursuant to stock option exercises (in shares)         33,442 33,442
Common stock issued pursuant to stock option exercises 735 735        
Stock-based compensation expense 3,983 3,983        
Other comprehensive income (loss), net of tax 75     75    
Vested restricted stock units converted to common stock (in shares)           330,350
Issuance of common stock in ATM offering, net of issuance costs (in shares)           150,000
Issuance of common stock in ATM offering, net of issuance costs $ 13,894 13,894        
Ending balance (in shares) at Mar. 31, 2025 28,530,337         28,530,337
Ending balance at Mar. 31, 2025 $ 257,405 $ 1,615,501 $ (1,359,003) $ 905   $ 2